HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis – involvement of ERK pathway  by Wang, Jing et al.
FEBS Letters 580 (2006) 2779–2787HCMV infection attenuates hydrogen peroxide induced
endothelial apoptosis – involvement of ERK pathway
Jing Wanga, Ying H. Shena, Budi Utamaa, Jian Wanga, Scott A. LeMairea, Joseph S. Cosellia,
Greg M. Vercellottib, Xing Li Wanga,*
a Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Adult Cardiac Services, Texas Heart Institute,
St. Luke’s Episcopal Hospital, Baylor College of Medicine, MS NAB 2010, One Baylor Plaza, Houston, TX 77030, USA
b Department of Medicine, University of Minneapolis, MN, USA
Received 2 January 2005; revised 21 March 2006; accepted 14 April 2006
Available online 25 April 2006
Edited by Lukas HuberAbstract Human cytomegalovirus (HCMV) exerts anti-apop-
totic eﬀect during early stage of infection, which provides
HCMV time for propagation. We investigated pathways mediat-
ing the resistance to H2O2-induced cell death – a self-defense
mechanism to remove infected cells. We found that human aortic
endothelial cells (HAECs) infected with VHL/E strain of
HCMV during ﬁrst 3 days were resistant to H2O2 (0–2 mM) in-
duced apoptosis. This anti-apoptotic eﬀect may be mediated by
the upregulation of Bcl-2, an anti-apoptotic protein through
the activation pro-survival pathway extracellular signal regu-
lated kinase (ERK). Through this mechanism, HCMV is able
to propagate and causes endothelial dysfunction, hence vascular
disease.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cytomegalovirus1. Introduction
Human cytomegalovirus (HCMV) – a ubiquitous b-herpes-
virus – has been associated with atherogenesis and coronary
restenosis by its infectivity in endothelial and smooth muscle
cells [1–3]. It is the most common pathogen aﬀecting more
than 50% human population in most parts of the world [4].
While majority of infected individuals are asymptomatic,
HCMV infection can cause severe illness in neonates and in
immunocompromised individuals, e.g. organ transplant recip-
ients. Understanding the mechanisms mediating HCMV-in-
duced pathological changes has major biological signiﬁcance
to human health.
Apoptosis is a highly regulated self-defense mechanism
involving the removal of senescent, abnormal, potentially
harmful cells such as virally infected cells from body system.
The deregulation of apoptotic mechanism contributes to a
variety of diseases. HCMV employs multiple strategies to sup-
press apoptosis during the early stage of infection in order to
create an optimal environment for the viral propagation
[5,6]; and to promote apoptosis at the late stage of infection*Corresponding author. Fax: +1 713 798 1705.
E-mail address: xlwang@bcm.tmc.edu (X.L. Wang).
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doi:10.1016/j.febslet.2006.04.041to facilitate viral dissemination [7]. Although the HCMV-med-
iated anti-apoptotic eﬀect is a well-described phenomenon, the
mechanisms for the eﬀect are not clear. Recent studies have
shown that HCMV encodes at least two proteins UL36 and
UL37 to directly interfere with the apoptotic signaling path-
ways [8,9]. However, these two molecules cannot satisfactorily
explain the anti-apoptotic process involved in HCMV infec-
tion to human cells [2,10]; and their involvements in endothe-
lial cells are also not clear.
Endothelial cells undergo apoptosis in response to stress,
such as growth factor withdrawal, UV irradiation, chemother-
apy and oxidative stress. When the apoptosis is moderate, it
can be protective; when it is excessive, it can be harmful and
pro-atherogenic. Hydrogen peroxide (H2O2) is a secondary
messenger in many cells to execute extracellular signals, such
as inﬂammation process. In response to infection, monocytes
or macrophages can produce a large amount of H2O2, as a part
of self-defense mechanisms, to eliminate cells infected with
pathogens, possibly by apoptosis induction. Of course, H2O2
as a major component of reactive oxygen species (ROS) is also
elevated in hypercholesterolemia or inﬂammation and pro-
motes atherogenesis. With these double-edged sword eﬀects,
it is biologically and clinically relevant to investigate whether
and how HCMV-infected endothelial cells would respond to
H2O2-induced apoptotic process. Understanding the mecha-
nisms responsible for these eﬀects will be of great value in
appreciating how HCMV infection triggers or accelerates
endothelial dysfunction and vascular diseases. In the current
study, we investigated the interactions between HCMV infec-
tion and H2O2 exposure in endothelial apoptosis. We have
demonstrated that HCMV-infected HAECs are resistant to
H2O2-induced apoptosis during the early stage of infection
by upregulating Bcl-2 through ERK pathway.2. Materials and methods
2.1. Reagents and antibodies
Bcl-2 (Cat#2872), phospho-Bcl-2 (Cat#2871), Bcl-xl (Cat #2762),
Bax (Cat #2772), Bad (Cat #9292), phospho-p44/42 MAPK
(Thr202/Tyr204) (Cat #4377), p44/42 MAPK (Cat #9012), Phospho-
Akt (Ser473) (Cat #9271), Akt(Cat #9272) antibodies and MEK1/2
inhibitor U0126 (Cat #9903) were purchased from Cell Signaling (Bev-
erly, MA). Mouse anti-HCMV immediate early antigen and late anti-
gen monoclonal antibody were from Chemicon International, Inc.
(Temecula, CA). Hydrogen peroxide 30% solution was purchased from
Sigma (St. Louis, MO).blished by Elsevier B.V. All rights reserved.
2780 J. Wang et al. / FEBS Letters 580 (2006) 2779–27872.2. Cell culture
Primary human aortic endothelial cells (HAECs) were purchased
from Cell Applications, Inc. (San Diego, CA) and cultured in EGM-
2 medium (Cambrex, Walkersville, MD) supplemented with 2% fetal
bovine serum, hydrocortisone, hFGF, VEGF, R-3IGF, hEGF, GA-
1000 and heparin. All experiments were carried out using HAECs in
passages 3–8.
2.3. HCMV infection and hydrogen peroxide treatment
The VHL/E (a generous gift from Dr. James Waldman) strain of
HCMV was used in the study [11]. For infection, HAECs were grown
to conﬂuence and infected with HCMV at 1.0 multiplicity of infection
(MOI). Cells were incubated at 37 C for 3 h for virus absorption. Cells
were then washed by PBS and continued the culture in EGM-2 growth
medium for 3 days. H2O2 was added to the cells at indicated doses and
time points. Following the treatment, cells were then washed with PBS
for three times and further cultured in EGM-2 growth medium for 16 h
before subjected to further analyses.
2.4. Terminal deoxynucleotidyltransferase-mediated dUTP nick-end
labeling (TUNEL) assay and immunocytochemistry staining
The TUNEL assay was performed to identify the apoptotic cell
using the in situ cell detection kit (BD Biosciences). In brief, HAECs
grown on gelatin-coated coverslips were washed twice by PBS, and
ﬁxed by 4% paraformaldehyde solution in PBS for 15 min at room
temperature. Coverslips were then washed with PBS and permeabilized
in 0.2% Triton X-100/PBS for 10 min. Each coverslip was added 50 ll
of the TUNEL reaction mixture and incubated in a dark humidiﬁed
chamber for 1 h at 37 C. The reaction was terminated by adding 2·
SSC and incubated at room temperature for 15 min. The cells were
then blocked with 1% BSA/PBS for 1 h, followed by incubating with
anti-HCMV immediate early (IE) antibody (Chemicon) and Texas
Red conjugated secondary antibody. The DNA dye DAPI (4 06 0 diami-
dino-2-phenylindole dihydrochloride) was used to label the nuclei at
the concentration 0.1 lg/ml for 30 min. The slides were examined with
a Leica DMLS Epiﬂuoresence microscope (20 ·–40· magniﬁcation).
The data were analyzed with the Image-Pro Plus V4.5 software (Media
Cybernetics, Inc).
2.5. Caspase-3 activity
The caspase-3 activity was determined using the Caspase-3 Assay Kit
(BD Biosciences). Brieﬂy, HAECs were grown in 6-well plates to con-
ﬂuence, infected with HCMV, and treated with H2O2 as indicated.
For each reaction, HAECs were washed with PBS and re-suspended
in cold Cell Lysis Buﬀer (10 mM Tris–HCl, 10 mM NaH2PO4/
K2HPO4, pH 7.5, 130 mMNaCl, 1% Triton-X 100, and 10 mM sodium
pyrophosphate) for 30 min on ice. Five microliter reconstituted cas-
pase-3 ﬂuogenic substrate Ac-DEVD-AMC [N-acetyl-Asp-Glu-Val-
Asp-AMC (7-anmino-4-methylcoumarin)] was added to each well
containing 0.2 ml of the 1· HEPES buﬀer before 30 ll of the cell lysate
was added. The reaction mixtures were incubated at 37 C for 1 h. The
amount of AMC liberated from Ac-DEVC-AMC was measured using
ultraviolet spectroﬂuorometry plate reader with the excitation wave-
length of 380 nm and an emission wavelength range of 420–460 nm.
Apoptotic cell lysates containing active caspase-3 yielded a considerable
emission as compared to non-apoptotic cell lysates. Relative caspase-3
activities were calculated according to the protein concentrations of the
cell lysates.
2.6. Mitochondrial membrane potential
The loss of mitochondrial membrane potential is a hallmark for
apoptosis. We used JC-1 Assay kit (Invitrogen, Carlsbad, CA) to mea-
sure the mitochondrial membrane potential in HCMV- and mock-in-
fected HAECs treated with or without 1 mM H2O2 for 3 h. In brief,
HAECs were grown in 6-well plates to conﬂuence. Cells were then
mock- or HCMV-infected, and treated with or without H2O2 as de-
scribed above. Cells were detached from the plate by short treatment
with trypsin, which was inactivated by adding trypsin neutralizing
solution (TNS, Cambrex). We then centrifuged the cell suspension at
400 · g for 5 min to remove the supernatant. Cells were resuspended
in 0.5 ml 1· JC-1 Reagent solution and incubated at 37 C in a 5%
CO2 incubator for 15 min. This was followed by a brief centrifugation
and the removal of the supernatant. Cells were then washed twice with
2 ml of 1· assay buﬀer. We resuspended the cell pellet in 0.5 ml of 1·assay buﬀer; and the JC-1 aggregation in mitochondria was quantiﬁed
using Flow Cytometry. JC-1 (5,5 06,6 0-tetrachloro-1,1 03,3 0-tetraethyl-
benzimidazolycarbocyanine iodide) stains mitochondria bright red in
normal cells. A loss in mitochondrial membrane potential prevents
JC-1 aggregation; and JC-1 remains as a monomer in the cytoplasm
and exhibits green ﬂuorescence.
2.7. Western blot analysis
Cells were lysed in Cell Lysis buﬀer (20 mM Tris–HCl, pH 7.5, 150
mMNaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1% Nonidet
P-40, 2.4 mM sodium pyrophosphate, 1 mM DTT, 1 mM PMSF
2 mM vanadate and 1· protease inhibitors cocktail from Sigma) by
incubation on ice for 1 h. The total protein concentration was deter-
mined with the protein assay kit (Bio-Rad Laboratories, Hercules,
CA). Fifty micrograms of protein samples was separated on 12%
SDS–PAGE gels for 1 h at 80 v, which was then transferred to the
nitrocellulose membrane. The membrane was blocked in 5% non-fat
powdered milk in TBST (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
and 0.05% Tween 20). The membrane was incubated with the primary
antibody at 4 C overnight, followed by incubation with HRP-conju-
gated secondary antibody and detected with SuperSignal West Pico
Chemiluminescent Substrate (Pierce, Rockford, IL). Equal loading
was conﬁrmed by the house-keeping control b-actin band.
2.8. RNA isolation and quantitative real-time RT-PCR
Mock- and HCMV-infected HAECs were treated with H2O2 as de-
scribed above. Total RNA was isolated using TRIzol reagent (Invitro-
gen, Carlsbad, CA). One microgram of total RNA was used for the
synthesis of cDNA by iScript cDNA Synthesis Kit (Bio-Rad). Real-
time PCR was performed using iQSYBR Green Supermix Kit (Bio-
Rad) following the manufacturer’s instruction. The quantitative gene
expression by real-time PCR was evaluated using the comparative
threshold cycle (CT) method and was normalized against the endoge-
nous control b-actin. The PCR primer sequences are Bcl-2 forward:
5 0-GGG GAG GAT TGT GGC CTT C-3 0, reverse: 5 0-CAG GGC
GAT GTT GTC CAC C-3 0; Bcl-xl forward: 5 0-GGT CGC ATT
GTG GCC TTT TTC -3 0, reverse: 5 0- GCT GCA TTG TTC CCA
TAG AG-30; Bax forward: 5 0- TGA GCA GAT CAT GAA GAC
AGG -3 0, reverse: 5 0- GAC ACT CGC TCA GCT TCT TG -3 0; b-actin
forward: 5 0-CTG GAA CGG TGA AGG TGA CA-3 0, reverse: 5 0-
AAG GGA CTT CCT GTA ACA ATG CA-3 0. All samples were
run in duplicates and were repeated at least three times.
2.9. Statistical analyses
Quantitative variables are presented as means ± S.D. of three sepa-
rate experiments, and compared by independent Student’s t test be-
tween groups and by ANOVA for comparisons among three or
more groups. Two-tailed P < 0.05 is regarded as statistically signiﬁ-
cant. The statistical analyses were conducted using SPSS 12.0 for
Windows (SPSS Inc., Chicago, IL).3. Results
3.1. HCMV attenuated H2O2-induced apoptosis in HAECs
It has been shown that HCMV suppresses cell death in many
cell types during early stage of infection [12–15]. Among sev-
eral laboratory strains (AD169, Towne), our previous data
demonstrated that HCMV VHL/E strain, an originally clinical
isolate, had a high rate of infection to the primary HAECs [7].
HAECs were mock- or HCMV-infected at MOI 1.0. Three
days after infection, cells exposed to 0 or 1 mM of H2O2 for
3 h. We identiﬁed cells undergoing apoptosis by in situ TU-
NEL staining with ﬂuorescein; and HCMV-infected cells were
identiﬁed with anti-IE antibody (Fig. 1). TUNEL is a sensitive
method to examine apoptosis via DNA fragmentation. By
microscopic examination, we detected very few TUNEL posi-
tive apoptotic cells (shown as green color, condensed nuclei co-
localized with DAPI nuclei stain) in HCMV-infected cells
without H2O2 treatment. After exposure to 1 mM H2O2 for
Fig. 1. HCMV infection protects HAECs from H2O2-induced apoptosis. HAECs were mock- and HCMV-infected at 1.0 MOI, and were treated
with 0 or 1 mMH2O2 for 3 h on 3 day post-infection. Cells were then stained with DAPI (blue) for nuclei, TUNEL (green) for apoptosis, and anti-IE
antibody for HCMV immediate early antigen (red). There were more TUNEL positive cells in mock-infected than in those in HCMV-infected cells.
Merged images show minimal co-localization between TUNEL and IE. The pictures shown are the representative of three separate experiments
repeated.
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TUNEL positive stained cells than non-H2O2-treated cells.
However, more apoptotic cells were observed in the mock-
infected cells than those in the HCMV-infected cells (Fig. 1).
We further quantiﬁed the number of the positively stained
cells by randomly choosing at least four diﬀerent visual ﬁelds
on each phase of the coverslips under microscope with low
magniﬁcation (20·), and counted the TUNEL positive cells
(green), HCMV IE positive cells (red), and DAPI nuclear
staining (blue) by Image-Pro Plus V4.5 software (Media
Cybernetics, Inc). The apoptosis rate and HCMV infection
rate were calculated by the total numbers of TUNEL positive
cells and IE positive cells divided by the total number of cells
as measured by the DAPI staining. At 3 days post-infection,
approximately 40% HAECs were infected by HCMV as indi-
cated by the positive IE staining.
HAECs were exposed to diﬀerent doses of H2O2 (0, 1,
2 mM). The percent of apoptotic endothelial cells was approx-
imately 2-fold higher in the mock-infected HAECs than those
in the HCMV-infected cells for each dose of H2O2 treatment.
The percentage of apoptotic cells was about 2.5-fold higher in
HAECs exposed to 2 mMH2O2 comparing to the cells without
the treatment (Fig. 2A). We also evaluated the time-dependent
changes in HAECs treated with 1 mM H2O2. At 0.5 h post
treatment, there was a slight induction of apoptosis in the
mock-infected culture. By the 2, 4 and 6 h post-H2O2 treatment,
there was a signiﬁcant increase in the positive staining for apop-
tosis in the mock-infected cells. The HCMV-infected cells, on
the other hand, had signiﬁcantly less apoptotic cells (Fig. 2B).These results indicate that HCMV infection can eﬀectively
attenuate H2O2-induced endothelial apoptosis.
3.2. Caspase-3 activation by the H2O2 exposure
Caspase activation is a crucial step in executing the apopto-
tic process. Among known caspases, caspase-3 activation often
indicates an irreversible stage of apoptotic induction and plays
an important role in various drug-induced apoptosis. We
investigated whether caspase-3 was involved in the H2O2-
induced endothelial apoptosis. We measured the intracellular
levels and activities of caspase-3 in the experimental HAECs.
As shown in Fig. 2C, caspase-3 activity increased signiﬁcantly
by the H2O2 treatment in a dose-dependent manner in the
mock-infected cells, which was about 20–40% higher than that
in the HCMV-infected cells with the treatment of 0–2 mM
H2O2.
3.3. Loss of mitochondrial membrane potential
The mitochondrial permeability transition is an important
step in the induction of apoptosis. We used JC-1 assay kit to
quantify the mitochondrial membrane potential in HCMV-
and mock-infected HAECs treated with or without H2O2.
The relative mitochondrial membrane potential was calculated
by comparing to the mock-infected control without H2O2
exposure (Fig. 2D). In the mock-infected HAECs, H2O2 treat-
ment reduced the mitochondrial membrane potential by 75.6%
comparing to the non-treatment control cells. On the other
hand, the mitochondrial potential was reduced only 31.6%
after the exposure to 1 mM of H2O2 for 3 h in the HCMV-
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Fig. 2. H2O2induces apoptosis in HAECs. (A) Dose dependent eﬀects of H2O2-induced apoptosis. HAECs were treated with H2O2 at indicated doses
for 3 h. TUNEL positive cells and total cells were counted in at least four randomly selected areas per coverslip under ﬂuorescence microscope (20·).
HCMV-infected cells had signiﬁcantly lower apoptosis rate compared to the mock-infected cells. (B) Time course of H2O2-induced apoptosis. HAECs
were treated with 1 mM H2O2 for 0–6 h. The percentage of apoptotic cells increased rapidly in the mock-infected cells, but remained low in HCMV-
infected cells. (C) Caspase-3 activity increased in a dose-dependent manner in the mock-infected cells. But there was virtually no change in HCMV-
infected cells. (D) Mitochondrial potential decreased when treated with 1 mM of H2O2. While HAECs infected with HCMV showed a lower
mitochondrial potential comparing to the mock-infected HAECs, further H2O2 treatment did not change the potential as signiﬁcant as that in the
mock-infected cells. All results presented in the ﬁgure were expressed as means + S.D. (n = 3) at each dose or time point from three individual
experiments. *P < 0.01 for diﬀerences between mock- and HCMV-infected groups by independent Student’s t test. For within group diﬀerences in
relation to dose- and time-dependent changes, oneway ANOVA was used, and P < 0.001 for the mock-infected cells, P > 0.05 for HCMV-infected
cells.
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infected HAECs with the same H2O2 treatment.
3.4. HCMV infection upregulated Bcl-2 expression in
endothelial cells
Our results showed that H2O2 increased endothelial cell
apoptosis by activating caspase-3 and loss of mitochondrial po-
tential, which appeared to be attenuated by HCMV infection.
To investigate the mechanism of anti-apoptotic eﬀect by the
HCMV, we measured the protein levels of Bcl-2 family mem-
bers: Bcl-2, Bcl-xl, Bax and Bad (Fig. 3A). HCMV immediate
early antigen (HCMV IE) and HCMV late antigen were also
examined to verify the HCMV infection status (Fig. 3A). Bcl-
2, a well-known anti-apoptotic protein, was elevated in the
HCMV-infected cells. Using Student’s t tests, we found that
Bcl-2 protein levels (expressed as density ratios relative to the
density of b-actin band) in HCMV-infected cells treated with
0, 1 and 2 mM H2O2 were signiﬁcantly higher than those
mock-infected cells receiving the same doses of H2O2 treatments
(1.12 ± 0.13 vs 1.59 ± 0.21, t = 5.88, P = 0.028; 1.16 ± 0.13 vs
1.53 ± 0.21, t = 4.38, P = 0.045; 0.95 ± 0.13 vs 1.54 ± 0.19,
t = 9.89, P = 0.01, N = 3, respectively). Bcl-2 protein level de-
creased, although non-signiﬁcantly, when mock-infected cells
were exposed to 1 or 2 mM H2O2 for 3 h. But HCMV-infected
cells did not show signiﬁcant changes in Bcl-2 level under the
same treatment ofH2O2. The Bcl-xl - the other pro-survival pro-
tein, was not aﬀected by the HCMV infection or the H2O2 treat-
ment. The same ﬁndings were also observed for Bax and Bad –
the pro-apoptotic proteins in the Bcl-2 family.
We further measured the Bcl-2, Bcl-xl and Bax mRNA levels
in these experimental cells. Similar to the protein levels, there
was a signiﬁcant increase in Bcl-2 mRNA in HCMV-infectedcells compared to the mock-infected cells (Fig. 4A). However,
H2O2 treatment did not change Bcl-2 mRNA levels in either
experimental group. There was virtually no diﬀerence in Bcl-
xl and Bax mRNA levels between HCMV- and mock-infected
cells with or without H2O2 treatment (Fig. 4B and C). These
results indicate that increased Bcl-2 mRNA transcription and
protein expression may contribute to the anti-apoptotic eﬀect
by the HCMV infection in endothelial cells against H2O2-
induced apoptosis.
3.5. Activation of ERK mediates the anti-apoptotic eﬀects in
HCMV-infected cells
We next sought to determine which cellular signal transduc-
tion pathways were involved in preventing HCMV-infected
HAECs from apoptosis. Various members of the MAPK fam-
ily have been implicated for their inﬂuences in cell survival
responding to stress. We attempted to ﬁnd out whether
HCMV infection might inhibit apoptosis through blocking
MAPK cascades in H2O2-treated cells. We examined the eﬀects
of H2O2 treatment and HCMV infection on the phosphoryla-
tion of ERK1/2 using antibodies speciﬁc for the phosphor-
ERK1/2(Thr202/Tyr204). HAECs treated with 1 or 2 mM
H2O2 for 3 h had signiﬁcantly reduced phospho-ERK 1/2 in
the mock-infected cells. However, the phospho-ERK 1/2 level
was unchanged with the same H2O2 treatment in the HCMV-
infected cells (Fig. 5). Thr202/Tyr204 are the conserved phos-
phorylation sites for ERK1/2; and are critical for ERK1/2
activation. Our results suggest that H2O2 treatment inhibits
ERK1/2 activation, hence induces HAEC apoptosis. HCMV
infection, however, blocks the H2O2-initiated ERK1/2 inhibi-
tion, hence attenuates apoptotic process in HCMV-infected
endothelial cells.
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Fig. 3. Changes in levels of Bcl-2 family proteins in mock-and HCMV-infected cells. (A) Western blotting analyses in mock-and HCMV-infected
HAECs. HAECs were grown to conﬂuence before infected with HCMV for 72 h. Cells were then treated with 0, 1 and 2 mM H2O2 for 3 h
(corresponding three lanes in mock- and HCMV-infected cells in the Western blot). Cell lysates containing 50 lg proteins were separated in a 12%
SDS–PAGE electrophoresis before transferred to a nitrocellulose membrane for immunoblotting against speciﬁc proteins as indicated. The
representative results from three separate experiments are shown. (B) Quantitative analyses of the Bcl-2, Bcl-xl, Bax and Bad levels in Western blot.
The relative band intensities are means + S.D. (n = 3) from at least three individual experiments and normalized against b-actin protein level.
Columns 1–6 represent cells treated with 0, 1 and 2 mM H2O2 for 3 h in mock-infected (lanes 1–3) and HCMV-infected (lanes 4–6) cells. While Bcl-2
levels were higher in HCMV-infected cells compared to the mock-infected cells (P < 0.05 by the Student’s t test between mock-infected and HCMV-
infected of the same H2O2 treatment), the changes in the levels of Bcl-xl, Bax and Bad were small with the indicated doses of H2O2. There was also a
reduction in Bcl-2 levels with the increased doses of H2O2.
J. Wang et al. / FEBS Letters 580 (2006) 2779–2787 27833.6. ERK1/2 activation involved in Bcl-2 upregulation in
HCMV-infected endothelial cells
MAPK-ERK is an important cell signal pathway involved in
cell survival. HCMV infection induced phosphorylation and
activation of ERK1/2, and thus increased the ability to prevent
H2O2-induced apoptosis. Since Bcl-2 expression was also
upregulated in HCMV-infected HAECs, we next examined
whether activation of ERK1/2 could contribute to the Bcl-2
expression in the course of HCMV infection. We analyzed
the changes in phospho-ERK and phospho-Bcl-2 (thr56) after
pre-incubation with U0126 – a chemical compound act as
MEK inhibitor [16]. HAECs were mock- and HCMV-infected
as described above. Cells were pre-incubated with 10 lM
U0126 for 2 h. The same volume of solvent DMSO was added
to the control wells. After 2 h of incubation, H2O2 at the indi-
cated doses was added to the cells and incubated for an addi-
tional 3 h. The cells were harvested for the preparation of cell
lysates for the Western blotting analysis and for total RNA
isolation. We showed a complete block of the ERK1/2 phos-
phorylation by the U0126 treatment in both mock- and
HCMV-infected cells, while the total ERK protein levels were
unchanged (Fig. 6A). Bcl-2 phosphorylation was also signiﬁ-
cantly inhibited in the U0126-treated cells; but total Bcl-2 as
well as Bcl-xl and Bax were not aﬀected by the U0126 treat-
ment (Fig. 6A). On the other hand, Bcl-2 mRNA levels were
signiﬁcantly reduced in mock- and HCMV-infected cells with
the treatment of U0126. However, Bcl-xl and Bax mRNA lev-
els did not change with the U0126 treatment (Fig. 6B). TU-
NEL staining proved that HAECs pre-incubated with U0126
had signiﬁcant higher apoptosis rate than those pre-incubated
only with DMSO (Fig. 6C). Taken together, these data suggest
that there is a correlation between the level of ERK activity
and Bcl-2 gene expression; and that ERK1/2 is involved in reg-
ulating the Bcl-2 gene expression. This ERK-Bcl-2 pathwaymay play an important role in HCMV-mediated anti-apoptotic
function in HAECs.4. Discussion
One of the unique features for viruses like HCMV is to
evade the host immune detection and elimination, which en-
ables the virus to infect a large number of people and co-exit
with humans for life time. Because of this lifelong existence,
HCMV plays an important role in the pathogenesis of vascular
diseases including atherosclerosis and restenosis [3,17,18]. In
addition, HCMV also appears to be able to hijack cell cycle
and cell survival machineries for the beneﬁt of viral propaga-
tion and dissemination. During early infection, HCMV makes
the host cells resistant to cell death so that the virus carrying
cells will not be removed from the body system. This gives
the HCMV suﬃcient time and material to propagate. Once this
process is completed, at the late stage of infection, HCMV
makes the infected cells more likely to die so that it helps the
viral dissemination. When the condition is not favorable,
HCMV can also stay dormant in latent form with minimal vir-
al activity so that it can stay under the radar screen of immune
surveillance and wait for the right condition, e.g. during immu-
nocompromised stage, to propagate again. Therefore, it is vital
to understand the molecular mechanisms mediating these pro-
cesses and to break the cycles that favor HCMV existence and
growth.
One of the signiﬁcant ﬁndings in the present study is that
HCMV-infected HAECs are resistant to H2O2-induced cell
death. H2O2 is an active ROS produced during the aerobic
metabolism under physiological conditions. In moderate
‘‘physiological’’ amount, H2O2 appears to promote cell growth
via ERK 1/2 pathway [19,20]. However, when produced in
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Fig. 4. Levels of mRNA of the Bcl-2 family members in HCMV-
infected cells. HAECs were grown to conﬂuence, and infected with
HCMV at MOI 1.0. On 3 days post-infection, cells were treated with
indicated doses of H2O2 for 3 h. Total RNA were isolated and used for
cDNA synthesis. Bcl-2 (A), Bcl-xl (B) and Bax (C) mRNA levels were
quantiﬁed by using quantitative real-time RT-PCR. The housekeeping
gene b-actin was used as an internal control. Levels of Bcl-2 mRNA
were signiﬁcantly higher in the HCMV-infected cells than the mock-
infected cells with or without H2O2 treatment. Levels of Bcl-xl and Bax
mRNA were not aﬀected by HCMV infection or H2O2 treatment. All
data are presented as means + S.D. of three individual experiments
(n = 3).
pErk (T202/Y204)
tErk
H2O2
Mock HCMV
Fig. 5. Activation of ERK after HCMV infection. HAECs were grown
to conﬂuence before infected with HCMV at MOI 1.0 for 3 days. Cells
were then treated with 0, 1, 2 mM H2O2 for 3 h (corresponding three
lanes in the Western blot) before harvested for the analyses of
phosphorylated and total ERK. While phospho-ERK was signiﬁcantly
elevated, the total ERK showed no change in HCMV-infected cells.
Representative Western blot gels from three separate experiments
(n = 3) are shown.
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H2O2 can cause tissue injuries, e.g. endothelial cell apoptosis,
and is associated with atherogenesis. It appears that H2O2
can increase mitochondria permeability or activate JNK/c-
Jun pathway, hence triggers endothelial apoptosis [21–23].
However, when the excess H2O2, e.g. released by the activated
monocytes or macrophages, is targeted at cells carrying patho-
gens, the cell death initiated by the H2O2 is beneﬁcial. Even
this relatively non-selective cell death pathway initiated by
H2O2 is blocked in cells with active HCMV propagation.
HCMV-infected HAECs had signiﬁcantly less cells undergoing
apoptosis when exposed to H2O2 (Fig. 2A and B). Cells that
did go apoptosis were mostly not yet infected by the HCMV
as illustrated by co-localized staining of TUNEL for apoptosis
and IE for HCMV infection (Fig. 1).
We have further shown that the expression of Bcl-2 – a pro-
survival protein, which was inhibited by H2O2 treatment, was
increased by the HCMV infection (Fig. 3A). The increase in
Bcl-2 mRNA levels in HCMV-infected endothelial cells sug-
gests that the HCMV will either promote Bcl-2 transcription
or stabilize the Bcl-2 mRNA. While no previous studies have
shown the relationship between HCMV infection and Bcl-2
expression in endothelial cells, Bcl-2 expression was increased
by the infection of other virus, e.g. human T-cell lymphotropic
virus type I, in endothelial cells [24]. Bcl-2 as a pro-oncogene
plays an important role in endothelial cell death [25–27]. In
addition to sustain cell survival for viral proliferation, elevated
Bcl-2 in endothelial cells could have an additional eﬀect on
angiogenesis, hence carcinogenesis [28]. This role could be
especially relevant when HCMV already produces its own
anti-apoptotic proteins, e.g. vMIA [29–31], which is unrelated
to Bcl-2 but capable of prolonging cell survival for pro-viral
proliferation environment. On the other hand, the Bcl-xl –
the other pro-survival Bcl-2 family protein, Bax and Bad –
the pro-apoptosis Bcl-2 family proteins, did not show changes.
However, these results cannot rule out the possibilities that
these Bcl-2 family proteins are involved in the anti-apoptotic
process during the HCMV infection. HCMV could regulate
these apoptosis-related proteins by altered subcellular translo-
cation, integration and oligomerization with the mitochondrial
membrane without causing level changes in the total cell ly-
sates. More experiments are needed to explore these changes.
Endothelial cells possess a multitude of redox-sensitive sig-
naling systems, including the extracellular signal-regulated ki-
nase (ERK1/2) and p38 MAPK, Akt, JNK and caspases
[32,33]. The best characterized among MAPKs is extracellular
signal regulated kinase (ERK). This kinase is activated by a
cascade of phosphorylation that involves initially in Ras inter-
action with Raf-1. Activation of Raf-1 in turn phosphorylates
MEK1 followed by phosphorylation of p44 (ERK1 isoform)
and p42 (ERK2 isoform) on tyrosine and threonine residues.
Mitogen-activated ERK is known to act as an anti-apoptotic
factor by mediating cell proliferation and survival [34]. Under
low level of oxidative stress, e.g. H2O2 concentration lower
than 100 lM, it induces activations of ERK, Akt, NF-jB
and acts as a pro-survival factor. When the concentration of
ROS (e.g. H2O2) is high, however, it promotes pro-apoptotic
changes. In our experiment, high concentrations of H2O2 (1
or 2 mM) resulted in a signiﬁcant reduction in phospho-
ERK in the mock-infected endothelial cells. However, this
repression was not evident in the HCMV-infected cells. These
data suggest that H2O2 may induce apoptosis by inhibiting
Fig. 6. HCMV infection increased total Bcl-2 levels and maintained the Bcl-2’s phosphorylation status; MEK inhibitor U0126 attenuated HCMV-
mediated eﬀects on Bcl-2. HAECs were infected with HCMV for 3 days. Cells were pre-incubated with DMSO or 10 lM of U0126 for 2 h, and were
treated with indicated amounts of H2O2 for 3 h. (A)Western blot for phospho-ERK, tERK, phospho-Bcl-2, Bcl-2, Bcl-xl and Bax. Fifty micrograms of
the cell lysate proteins was loaded and separated by 12% SDS–PAGE. Cells were treated with 0, 1 and 2 mM H2O2 in the corresponding lanes. (B)
Changes in mRNA levels of Bcl-2 in cells treated with U0126. Total RNA was isolated and used for the cDNA synthesis. Bcl-2, Bcl-xl and Bax mRNA
levels were quantiﬁed by using real-time PCR and were normalized against b-actin. Data represent the means + S.D., n = 3. While the Bcl-2 mRNA
levels were similar between mock-infected and HCMV-infected cells treated with U0126, they were elevated by the HCMV infection in cells treated
with vehicle DMSO only (P < 0.05 for 1 or 2 mM H2O2, respectively). (C) MEK inhibitor U0126 increased apoptosis in both mock-infected and
HCMV-infected HAECs. HAECs were infected and pre-incubated with DMSO or 10 lM of U0126 as described in Section 2; and then treated with
1 mM of H2O2 for 3 h. Cells were ﬁxed and stained by the TUNEL kit to evaluate the apoptosis rate. All percentages of apoptosis are means + S.D.
of three separate experiments (n = 3). In all treatment conditions, except those treated with U0126 + H2O2, the rates of apoptosis were signiﬁcantly
lower in the HCMV-infected HAECs than those in the mock-infected cells (*P < 0.01). Yet, the U0126 treatment abolished the HCMV infection-
mediated diﬀerence in H2O2-induced HAEC apoptosis. On the other hand, U0126 pre-incubation with or without simultaneous H2O2 treatments
signiﬁcantly increased apoptosis rate in both mock- and HCMV-infected HAECs (P < 0.05). While HCMV infection signiﬁcantly inhibited H2O2-
induced endothelial apoptosis, the diﬀerence was no longer present by the simultaneous U0126 treatment.
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the ERK1/2, thus attenuates the H2O2-induced apoptosis.
The MAP kinase pathway is known to aﬀect the expression
of genes involved in cell survival [35,36]. The fact that the
Bcl-2 and the ERK signaling pathways are both implicated
in controlling cell viability suggests that MAP kinase could
be the upstream regulator of Bcl-2, as suggested in several re-
cent studies [37–39]. Indeed, our experiment in cells (with or
without HCMV infection) treated with U0126 – a chemical
inhibitor of MKK1/2 [16] has demonstrated the reduced Bcl-
2 mRNA and protein levels with the decreased phosphor-
ERK.
Recent studies have established that Bcl-2 function is
primarily modulated by heterdimerization with other pro-apop-
totic members in the Bcl-2 family. Phosphorylation of Bcl-2
could play an important role in this regulatory mechanism. Sev-eral types of Bcl-2 phosphorylation have been reported [40], and
are associated with Bcl-2 activation [41–45]. Our results showed
that H2O2 treatment was able to reduce the Bcl-2 phosphoryla-
tion at the Thr 56 residue in mock-infected cells. However,
H2O2 was unable to change the phospho-Bcl-2 levels in the
HCMV-infected cells (Fig. 6A). Pre-incubation of HAECs with
U0126 – an ERK inhibitor, completely blocked the Bcl-2 phos-
phorylation. Bcl-2 mRNA level was also decreased after pre-
treatment with U0126 (Fig. 6B). These changes were translated
into an increased endothelial apoptosis with the H2O2 exposure
(Fig. 6C). Indeed, the percentages of endothelial apoptosis were
similar in mock- and HCMV-infected cells when treated with
U0126 and H2O2 (Fig. 6C). Our results indicate that ERK1/2
may act as an upstream regulator of Bcl-2 and is involved in
the maintenance of the Bcl-2 phosphorylation status at the
Thr 56 residue. Functional relevance of this phosphorylation
2786 J. Wang et al. / FEBS Letters 580 (2006) 2779–2787requires further investigation, especially in endothelial cells in-
fected with HCMV.
In conclusion, we have shown that HCMV interferes with
endothelial apoptosis initiated by H2O2. Because HCMV rep-
licates to high titers during ﬁrst few days post-infection in
endothelial cells, this anti-apoptotic eﬀect by HCMV confers
the virus a signiﬁcant survival advantage. Our study has fur-
ther suggested that pro-survival pathways initiated by the
ERK activation and Bcl-2 may be responsible for the anti-
apoptotic eﬀect when challenged by oxidative stress. Indeed,
this pro-survival environment initiated by the HCMV infection
may be a universal mechanism for the virus-mediated apopto-
sis resistance. Rather than directly interfering with the pro-
apoptotic pathways, HCMV may counter-balance the eﬀect
by boosting up the pro-survival machineries. It may be eﬀec-
tive not only to H2O2-initiated apoptotic process, but also to
other apoptotic triggers including UV irradiation, growth fac-
tor withdraw or TNF-a stimulation. Although more investiga-
tions are needed, interrupting the pro-survival pathways rather
than activating pro-apoptotic pathways could be more eﬀec-
tive in breaking the propagation cycle initiated by HCMV
infection, hence minimizing the pathological changes.
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